Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/782| Title: | Code of practice for the pharmaceutical industry 2021/ |
| Keywords: | Pharmaceutical industry Pharmaceutical ethics Drug promotion Code of practice Transparency Self-regulation |
| Issue Date: | 1-Jan-2021 |
| Publisher: | Farmaindustria |
| Abstract: | The Code of Good Practices for the Pharmaceutical Industry establishes ethical standards governing the promotion of prescription medicines and interactions between pharmaceutical companies, healthcare professionals, healthcare organisations, and patient organisations. It promotes accurate and objective medicine information, professional conduct, transparency, integrity, and responsible collaboration. The 2021 edition addresses pharmaceutical promotion, scientific and educational activities, digital communication, disclosure of professional relationships, and mechanisms for monitoring compliance. The code aims to strengthen public trust, protect patients’ interests, and encourage ethical practices within the pharmaceutical industry. |
| Description: | 120 pages: illustrations (chiefly colour); The document is a corporate code of practice, so Farmaindustria should be entered as the corporate author. If your copy is the September 2021 revised version, record that revision in the edition or notes field as appropriate. |
| URI: | http://localhost:8080/xmlui/handle/123456789/782 |
| Appears in Collections: | Pharmacy |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Code of Practice for the pharmceutical industry.pdf | 1.88 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.